transparent gif
AlzheimerSupport.com Home  
Landmark Book Commemorates Centennial of Discovery of Alzheimer's Disease
Alzheimers Home Page Alzheimers Library Alzheimers Treatment and Research Email bulletins Alzheimers Products Alzheimers Community Area Alzheimers About Us transparent gif transparent gif
transparent gif
background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
 Alzheimers Info.
Alzheimers Resources

Your Support Funds Research & Advocacy

Landmark Book Commemorates Centennial of Discovery of Alzheimer's Disease


alzheimersupport.com

04-10-2006

Advertisement
Source: Case Western Reserve University

IOS Press is pleased to announce the forthcoming publication of a landmark work commemorating the centennial of Alois Alzheimer's discovery of what would be known as Alzheimer's disease (AD). The book, Alzheimer's Disease: A Century of Scientific and Clinical research, is scheduled for publication in July 2006 and its release will coincide with the 10th International Conference on Alzheimer's Disease and Related Disorders, July 15-20 in Madrid.

The centennial of Alois Alzheimer's original description of the disease that would come to bear his name offers a vantage point from which to commemorate the seminal discoveries in the field. This milestone work has been guided by four of the most prominent voices in the field today, George Perry, Dean of the University of Texas at San Antonio College of Sciences and Professor of Pathology and Neurosciences, Case Western Reserve University, Editor-in-Chief, Journal of Alzheimer's Disease; Jesús Avila, Center for Molecular Biology, University Autónoma of Madrid, Senior Editor, Journal of Alzheimer's Disease; June Kinoshita, Executive Editor, Alzheimer research Forum; and Mark A. Smith, Department of Pathology, Case Western Reserve University, Co-Editor-in-Chief, Journal of Alzheimer's Disease. It traces how the true importance of AD as the major cause of late life dementia ultimately came to light and narrates the evolution of the concepts related to AD throughout the years and its recognition as a major public health problem, with an estimated 30-40 million people affected by AD today.

George Perry commented, "The book will bring to life, and in many instances revisit and reflect on, the classic studies that have essentially defined Alzheimer's disease research. My co-editors and I are extremely pleased that this project has attracted participation from nearly every single player in the field and, having read each contribution, I am convinced that the book is destined to become one of the defining works in the field."

To identify the breakthroughs, the editors have used citation analysis, landmark papers identified by current researchers, and drew upon their own experience and insights. This process took into account the perspectives of individuals who recall the impact of findings at the time they were made, as well as of scientists today who have the advantage of hindsight in weighing the lasting influence of these findings. Because modern AD research was triggered by the seminal work of Tomlinson, Blessed, and Roth some four decades ago, it is particularly fortunate that the vast majority of these milestone authors are still with us.

Each contributor was invited to discuss what made his or her particular article a milestone in the context of its time. Furthermore, contributors were asked to provide a highly personal perspective, by recounting the tale of how each discovery unfolded and by frankly describing the contradictions among studies and the debates that once took place in whispered tones in remote corners of seminar rooms and conference halls.

According to Dr. Perry, "These writings bring to the practitioner, student and interested lay person a perspective not only on the past, but also on where the Alzheimer's disease field is likely to go in the future. Only time will tell whether these milestones have charted the future accurately, but they are unquestionably the foundation upon which the future will be built."

Alzheimer's Disease: A Century of Scientific and Clinical research Edited by George Perry, Jesús Avila, June Kinoshita and Mark A. Smith July 2006, approx. 400 pages, hardcover ISBN: 1-58603-619-x US$150 / €120 / £82 (Will also be published as a special issue of the Journal of Alzheimer's Disease.)

TABLE of CONTENTS

Historical Perspective Jesse F. Ballenger Progress in the History of Alzheimer's Disease: The Importance of Context

José Manuel Martínez Lage 100 Years of Alzheimer's Disease (1906-2006)

Neuropathology Melvyn J. Ball The Essential Lesion of Alzheimer Disease: A Surprise in Retrospect

Heiko Braak, Udo Rüb, Christian Schultz, Kelly Del Tredici Vulnerability of Cortical Neurons to Alzheimer's and Parkinson's Diseases

Bernardino Ghetti Neurodegeneration and Hereditary Dementias: 40 Years of Learning

Asao Hirano and Maki Iida Topographic Study of Alzheimer's Neurofibrillary Changes: A Personal Perspective

Kurt A. Jellinger Clinicopathological Analysis of Dementia Disorders in the Elderly - An Update

Michael Kidd The History of the Paired Helical Filaments

Synaptic Changes M.M Esiri and S.A. Chance Vulnerability to Alzheimer's Pathology in Neocortex: The Roles of Plasticity and Columnar Organization

Eliezer Masliah, Leslie Crews and Lawrence Hansen Synaptic Remodeling during Aging and in Alzheimer's Disease

Stephen W. Scheff and Douglas A. Price Alzheimer's Disease-Related Alterations in Synaptic Density: Neocortex and Hippocampus

Robert D. Terry My Own Experience in Early research on Alzheimer Disease

Amyloid Karen H. Ashe Molecular Basis of Memory Loss in the Tg2576 Mouse Model of Alzheimer Disease

Massimo Tabaton and Pierluigi Gambetti Soluble Amyloid-ß in the Brain: The Scarlet Pimpernel

Dora Games, Manuel Buttini, Dione Kobayashi, Dale Schenk and Peter Seubert Mice as Models: Transgenic Approaches and Alzheimer's Disease

John Hardy The Amyloid Cascade Hypothesis: An update and Reappraisal

Colin L Masters and Konrad Beyreuther Pathways to the Discovery of the Aß Amyloid of Alzheimer's Disease

Dennis J. Selkoe Amyloid ß-Peptide Is Produced by Cultured Cells during Normal Metabolism: A Reprise

Tau Jesús Avila Tau Protein, the Main Component of Paired Helical Filaments

Jean-Pierre Brion Immunological Demonstration of Tau Protein in Neurofibrillary Tangles of Alzheimer's Disease

André Delacourte The Natural and Molecular History of Alzheimer's Disease

Michel Goedert, Aaron Klug and R. Anthony Crowther Tau Protein, the Paired Helical Filament and Alzheimer's Disease

Yasuo Ihara Neurofibrillary Tangles/Paired Helical Filaments (1981-83)

Khalid Iqbal and Inge Grundke-Iqbal Discoveries of Tau, Abnormally Hyperphosphorylated Tau and Others of Neurofibrillary Degeneration: A Personal Historical Perspective

Gail V.W. Johnson Tau Phosphorylation and Proteolysis: Insights and Perspectives

Kenneth S. Kosik Traveling the Tau Pathway: A Personnel Account

Virginia M.-Y. Lee and John Q. Trojanowski Progress from Alzheimer's Tangles to Pathological Tau Points Towards More Effective Therapies Now

Disease Mechanisms Peter Davies A Long Trek Down the Pathways of Cell Death in Alzheimer's Disease

Patrick L. McGeer, Joseph Rogers and Edith G. McGeer Inflammation, Antiinflammatory Agents and Alzheimer Disease: The Last 12 Years

Ralph A. Nixon and Anne M Cataldo Lysosomal System Pathways: Genes to Neurodegeneration in Alzheimer's Disease

Daniel P. Perl, Sharon Moalem Aluminum and Alzheimer's Disease, A Personal Perspective After 25 Years

George Perry When Is the Insoluble Solvable?

Mark A. Smith Oxidative Stress and Iron Imbalance in Alzheimer Disease: How Rust Became the Fuss!

Akihiko Takashima GSK-3 Is Essential in the Pathogenesis of Alzheimer's Disease

F.W.van Leeuwen, E.M. Hol and D.F. Fischer Frameshift Proteins in Alzheimer's Disease and in Other Conformational Disorders: Time for the Ubiquitin-Proteasome System

Genetics Efrat Levy, Frances Prelli and Blas Frangione Studies on the First Described Alzheimer's Disease Amyloid ß Mutant, the Dutch Variant

Alison Goate Segregation of a Missense Mutation in the Amyloid ß-Protein Precursor Gene with Familial Alzheimer's Disease

Dmitry Goldgaber The Discovery and Mapping to Chromosome 21 of the Alzheimer Amyloid Gene: My Story

Allen D. Roses On the Discovery of the Genetic Association of Apolipoprotein E Genotypes and Common Late-Onset Alzheimer Disease

Gerard D. Schellenberg Early Alzheimer's Disease Genetics

Maria Grazia Spillantini, Jill R. Murrell, Michel Goedert, Martin Farlow, Aaron Klug and Bernardino Ghetti Mutations in the Tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD)

Ekaterina Rogaeva, Toshitaka Kawarai and Peter St George-Hyslop Genetic Complexity of Alzheimer's Disease: Successes and Challenges

Christine Van Broeckhoven and Samir Kumar-Singh Genetics and Pathology of Alpha-Secretase Site AßPP Mutations in Understanding of Alzheimer's Disease

Diagnosis and Treatment Jesse Skoch, Bradley T. Hyman and Brian J. Bacskai Preclinical Characterization of Amyloid Imaging Probes with Multiphoton Microscopy

Zaven Khachaturian Diagnosis of Alzheimer's Disease: Two-Decades of Progress

Ian G. McKeith Consensus Guidelines for the Clinical and Pathologic Diagnosis of Dementia with Lewy Bodies (DLB): Report of the Consortium on DLB International Workshop

Dave Morgan Immunotherapy for Alzheimer's Disease

Beka Solomon Alzheimer's Disease Immunotherapy: From in vitro Amyloid Immunomodulation to in vivo Vaccination

William Summers Tacrine and Alzheimer's Treatments

Peter J. Whitehouse Quality of Life: The Bridge from the Cholinergic Basal Forebrain to Cognitive Science and Bioethics

About the Journal of Alzheimer's Disease The Journal of Alzheimer's Disease (www.j-alz.com) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease.

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
Research: New Compound Stops Brain Cell Degeneration in Alzheimer's Disease
Rating of 3
Researchers Identify Potential New Drug Target for Alzheimer's Disease
Rating of 3.1
Penn Researchers Discover the Powerful Tool of Simultaneous fMRI and PET Brain Imaging
Rating of 3
National Institute on Aging Awards UCI $9 Million to Continue Alzheimer's Disease Research
Rating of 2.9

Every purchase funds research, donations and the community resources provided within our website.

Organic & pure - 100% acacia
RenewLife Clear Fiber

Buffered for easy absorption
Pro-C Complex™ 500mg

Our new proprietary energy NADH
Energy NADH™ 10 mg

Getting your daily supplements has never been easier!
Daily Health ProPack™

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's AlzheimerSupport.com-
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee